Interferon α induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin

Molecular Biology of the Cell

Volumn 19, Issue 1, 2008, Pages 41-50

  Panaretakis, Theocharis ^a   Hjortsberg, Linn ^a   Tamm, Katja Pokrovskaja ^a   Björklund, Ann Charlotte ^a   Joseph, Bertrand ^b   Grander, Dan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMAGING; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, DOMINANT; HUMANS; INTERFERON-ALPHA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; STAT TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 38749146809     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-04-0358     Document Type: Article

References (40)

1. Baek, S. H., Lee, U. Y., Park, E. M., Han, M. Y., Lee, Y. S., and Park, Y. M. (2001). Role of protein kinase Cdelta in transmitting hypoxia signal to HSF and HIF-1. J. Cell. Physiol. 188, 223-235.
2. Burfoot, M. S., Rogers, N. C., Watling, D., Smith, J. M., Pons, S., Paonessaw, G., Pellegrini, S., White, M. F., and Kerr, I. M. (1997). Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J. Biol. Chem. 272, 24183-24190.
3. Caraglia, M. et al. (1999). Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ. 6, 773-780.
4. Carpenter, L., Cordery, D., and Biden, T. J. (2001). Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells. J. Biol. Chem. 276, 5368-5374.
5. Darnell, J. E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
6. Davis, R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
7. Ghayur, T. et al. (1996). Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184, 2399-2404.
8. Grander, D. (2000). How does interferon-alpha exert its antitumour activity in multiple myeloma? Acta Oncol. 39, 801-805.
9. Griffiths, G. J., Dubrez, L., Morgan, C. P., Jones, N. A., Whitehouse, J., Corfe, B. M., Dive, C., and Hickman, J. A. (1999). Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J. Cell Biol. 144, 903-914.
10. Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H., Mercola, D., and Murata, Y. (1999). Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 274, 31648-31654.
11. Ihle, J. N., and Kerr, I. M. (1995). Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11, 69-74.
12. Katsoulidis, E., Li, Y., Mears, H., and Platanias, L. C. (2005). The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J. Interferon Cytokine Res. 25, 749-756.
13. Kaur, S. et al. (2005). Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Exp. Hematol. 33, 550-557.
14. Kikkawa, U., Matsuzaki, H., and Yamamoto, T. (2002). Protein kinase C delta (PKC delta): activation mechanisms and functions. J. Biochem. 132, 831-839.
15. Koriyama, H., Kouchi, Z., Umeda, T., Saido, T. C., Momoi, T., Ishiura, S., and Suzuki, K. (1999). Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cell Signal. 11, 831-838.
16. Kumar, V., Pandey, P., Sabatini, D., Kumar, M., Majumder, P. K., Bharti, A., Carmichael, G., Kufe, D., and Kharbanda, S. (2000). Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation. EMBO J. 19, 1087-1097.
17. Leers, M. P. et al. (1999). Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187, 567-572.
18. Lei, K., and Davis, R. J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA 100, 2432-2437.
19. Li, W., Yu, J. C., Shin, D. Y., and Pierce, J. H. (1995). Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity. J. Biol. Chem. 270, 8311-8318.
20. Manabe, A., Yi, T., Kumagai, M., and Campana, D. (1993). Use of stromasupported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 7, 1990-1995.
21. Mandic, A., Hansson, J., Linder, S., and Shoshan, M. C. (2003). Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 278, 9100-9106.
22. Mitsutake, N., Namba, H., Shklyaev, S. S., Tsukazaki, T., Ohtsuru, A., Ohba, M., Kuroki, T., Ayabe, H., and Yamashita, S. (2001). PKC delta mediates ionizing radiation-induced activation of c-Jun NH(2)-terminal kinase through MKK7 in human thyroid cells. Oncogene 20, 989-996.
23. Nguyen, H., Ramana, C. V., Bayes, J., and Stark, G. R. (2001). Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J. Biol. Chem. 276, 33361-33368.
24. Nilsson, K., Bennich, H., Johansson, S. G., and Ponten, J. (1970). Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp. Immunol. 7, 477-489.
25. Panaretakis, T., Laane, E., Pokrovskaja, K., Bjorklund, A. C., Moustakas, A., Zhivotovsky, B., Heyman, M., Shoshan, M. C., and Grander, D. (2005). Doxorubicin requires the sequential activation of caspase-2, protein kinase C{delta}, and c-Jun NH2-terminal kinase to induce apoptosis. Mol. Biol. Cell 16, 3821-3831.
26. Panaretakis, T., Pokrovskaja, K., Shoshan, M. C., and Grander, D. (2002). Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J. Biol. Chem. 277, 44317-44326.
27. Panaretakis, T., Pokrovskaja, K., Shoshan, M. C., and Grander, D. (2003). Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 22, 4543-4556.
28. Parmar, S., and Platanias, L. C. (2003). Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15, 431-439.
29. Persons, D. L., Yazlovitskaya, E. M., Cui, W., and Pelling, J. C. (1999). Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5, 1007-1014.
30. Poste, G. (1972). Enucleation of mammalian cells by cytochalasin B. I. Characterization of anucleate cells. Exp. Cell Res. 73, 273-286.
31. Rhim, J. S. (1989). Neoplastic transformation of human epithelial cells in vitro. Anticancer Res. 9, 1345-1365.
32. Shoelson, S. E., Chatterjee, S., Chaudhuri, M., and White, M. F. (1992). YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc. Natl. Acad. Sci. USA 89, 2027-2031.
33. Strander, H., and Einhorn, S. (1996). Interferons and the tumor cell. Biotherapy 8, 213-218.
34. Takada, E., Shimo, K., Hata, K., Abiake, M., Mukai, Y., Moriyama, M., Heasley, L., and Mizuguchi, J. (2005). Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells. Exp. Cell Res. 304, 518-530.
35. Thyrell, L., Erickson, S., Zhivotovsky, B., Pokrovskaja, K., Sangfelt, O., Castro, J., Einhorn, S., and Grander, D. (2002). Mechanisms of Interferon-alpha induced apoptosis in malignant cells. Oncogene 21, 1251-1262.
36. Thyrell, L., Hjortsberg, L., Arulampalam, V., Panaretakis, T., Uhles, S., Dagnell, M., Zhivotovsky, B., Leibiger, I., Grander, D., and Pokrovskaja, K. (2004). Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J. Biol. Chem. 279, 24152-24162.
37. Uddin, S., Sassano, A., Deb, D. K., Verma, A., Majchrzak, B., Rahman, A., Malik, A. B., Fish, E. N., and Platanias, L. C. (2002). Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem. 277, 14408-14416.
38. Ueda, Y., Hirai, S., Osada, S., Suzuki, A., Mizuno, K., and Ohno, S. (1996). Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem. 271, 23512-23519.
39. Wang, G. Q., Gastman, B. R., Wieckowski, E., Goldstein, L. A., Gambotto, A., Kim, T. H., Fang, B., Rabinovitz, A., Yin, X. M., and Rabinowich, H. (2001). A role for mitochondrial Bak in apoptotic response to anticancer drugs. J. Biol. Chem. 276, 34307-34317.
40. Zhao, K. W., Li, D., Zhao, Q., Huang, Y., Silverman, R. H., Sims, P. J., and Chen, G. Q. (2005). Interferon-alpha-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cdelta and JNK. J. Biol. Chem. 280, 42707-42714.